| 6 | EndocannabinoidsIBA
01/2019
-
03/2005 |
| 4 | CannabinoidsIBA
01/2016
-
04/2003 |
| 4 | CytokinesIBA
09/2010
-
05/2002 |
| 3 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2008
-
11/2005 |
| 2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2022
-
06/2008 |
| 2 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2005
-
05/2002 |
| 2 | Interleukin-10 (Interleukin 10)IBA
06/2002
-
05/2002 |
| 2 | Interleukin-4 (Interleukin 4)IBA
06/2002
-
05/2002 |
| 1 | Brain-Derived Neurotrophic Factor (BDNF)IBA
12/2022 |
| 1 | Chemokine CCL11IBA
12/2022 |
| 1 | Biomarkers (Surrogate Marker)IBA
01/2022 |
| 1 | Creatine Kinase (Creatine Phosphokinase)IBA
01/2022 |
| 1 | Fatty Acid Synthases (Fatty Acid Synthase)IBA
01/2021 |
| 1 | Proteins (Proteins, Gene)FDA Link
01/2021 |
| 1 | Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
01/2021 |
| 1 | Tryptophan (L-Tryptophan)FDA Link
01/2021 |
| 1 | Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
01/2021 |
| 1 | Myosin-Light-Chain PhosphataseIBA
01/2021 |
| 1 | Voltage-Dependent Anion Channel 1IBA
01/2021 |
| 1 | Dihydrolipoyllysine-Residue Acetyltransferase (Dihydrolipoyl Transacetylase)IBA
01/2021 |
| 1 | AutoantibodiesIBA
01/2018 |
| 1 | AntibodiesIBA
01/2018 |
| 1 | ProgesteroneFDA LinkGeneric
05/2014 |
| 1 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
09/2012 |
| 1 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
09/2012 |
| 1 | AntigensIBA
09/2012 |
| 1 | Therapeutic UsesIBA
09/2012 |
| 1 | Cannabinoid Receptor AgonistsIBA
09/2012 |
| 1 | ChemokinesIBA
09/2010 |
| 1 | glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA
05/2010 |
| 1 | Transforming Growth Factor beta (TGF-beta)IBA
06/2008 |
| 1 | Angiotensin IIIBA
06/2008 |
| 1 | Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
06/2008 |
| 1 | EndotoxinsIBA
08/2007 |
| 1 | LipopolysaccharidesIBA
08/2007 |
| 1 | Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2005 |
| 1 | Interleukin-1beta (Interleukin 1 beta)IBA
11/2005 |
| 1 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2005 |
| 1 | N- (3- furylmethyl)eicosa- 5,8,11,14- tetraenamideIBA
11/2005 |
| 1 | anandamide (arachidonylethanolamide)IBA
11/2005 |
| 1 | Free RadicalsIBA
11/2005 |
| 1 | Interleukin-6 (Interleukin 6)IBA
11/2005 |
| 1 | EnzymesIBA
11/2005 |
| 1 | Ethanolamine (Colamine)IBA
03/2005 |
| 1 | Interleukin-1 (Interleukin 1)IBA
07/2002 |
| 1 | I kappa B beta proteinIBA
06/2002 |
| 1 | NF-kappa B (NF-kB)IBA
06/2002 |
| 1 | NF-KappaB Inhibitor alphaIBA
06/2002 |
| 1 | Messenger RNA (mRNA)IBA
06/2002 |
| 1 | ProstaglandinsIBA
05/2002 |
| 1 | Dinoprostone (PGE2)FDA Link
05/2002 |
| 1 | Prostaglandins EIBA
05/2002 |
